FDA approves Moderna's first mRNA-based influenza vaccine
The FDA approved the first mRNA-based influenza vaccine, developed by Moderna, for adults ages 50 and older. The approval marks a milestone for mRNA technology first widely used during the COVID-19 pandemic, though multiple posts raise safety and efficacy concerns.
Detected & updated continuously · Source: Nebula
Story subjects
Sources
@dcexaminer
The Food and Drug Administration approved the first mRNA-based influenza vaccine, marking a milestone for the technology, which was first widely used during the COVID-19 pandemic. The vaccine, developed by Moderna, is approved for adults ages 50 to 64 and those 65 and older, who https://t.co/oqVD8RUETi
@jsolomonReports
It takes 5,000 jabs of Moderna's just-approved mRNA flu vaccine to prevent one more hospitalization compared to a standard flu vaccine, but the new shot causes six times more injuries. @alexberenson first flagged the disparity. https://t.co/iG8BdPdasM
@GrammyC4Zone2
More irresponsible bullsh*t! 👇 Here We Go Again: FDA Approves First-Ever Moderna mRNA Flu Shot, Reportedly With No Key Testing, Worse Safety Than Normal Flu Shots. https://t.co/qR3AfLTSJC
@LionLeonidas3
Die Aktien von Moderna fallen, nachdem der von mRNA-Technologie basierte Grippeimpfstoff des Unternehmens zugelassen wurde. Investoren wissen, dass mRNA eine biologische Waffe ist... https://t.co/AJRf21s3Be
@Trader4lyf
This makes no sense unless its a trial baloon experiment and they want to see if we will push back hard enough! Enough is enough. Push back on these untested MRNA products
@CherylGrainger4
MRNA just accepted by the Regulators because that is where their investment is. STOP mRNA products now!!